Predictions
Delivery Hero SE
Start price
Target price
Perf. (%)
€70.22
04.01.20
04.01.20
€150.00
04.11.21
04.11.21
87.27%
06.09.21
06.09.21
Could be worthwhile Investment >10% per year
Nemetschek SE
Start price
Target price
Perf. (%)
€61.45
04.01.20
04.01.20
€61.00
04.11.21
04.11.21
77.87%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Nemetschek SE
Start price
Target price
Perf. (%)
€61.45
04.01.20
04.01.20
€61.00
04.11.21
04.11.21
77.87%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
CA Immobilien Anlagen AG
Start price
Target price
Perf. (%)
€37.85
03.01.20
03.01.20
€45.00
04.11.21
04.11.21
-5.81%
28.05.21
28.05.21
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.38
20.12.19
20.12.19
€86.00
23.04.20
23.04.20
21.40%
23.04.20
23.04.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.38
20.12.19
20.12.19
€86.00
23.04.20
23.04.20
21.40%
23.04.20
23.04.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.38
20.12.19
20.12.19
€86.00
23.04.20
23.04.20
21.40%
23.04.20
23.04.20
Fedex Corp.
Start price
Target price
Perf. (%)
€136.70
18.12.19
18.12.19
€150.00
18.12.19
18.12.19
-3.16%
18.12.19
18.12.19
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.46
17.12.19
17.12.19
€6.00
04.11.21
04.11.21
103.76%
05.11.21
05.11.21
TeamViewer AG
Start price
Target price
Perf. (%)
€28.94
11.12.19
11.12.19
€20.00
04.11.21
04.11.21
-56.03%
01.11.21
01.11.21
EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE lower than 10% per year
Below average Management